EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.3.2.6 | Neoplasms |
8615763 |
The human leukotriene A4 hydrolase gene is expressed in two alternatively spliced mRNA forms. |
causal interaction ongoing research unassigned |
1 4 0 |
3.3.2.6 | Neoplasms |
8918363 |
Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 4 3 |
3.3.2.6 | Neoplasms |
9608670 |
Leukotriene B4. |
causal interaction unassigned |
4 0 |
3.3.2.6 | Neoplasms |
12865451 |
Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin. |
causal interaction diagnostic usage ongoing research unassigned |
1 3 4 0 |
3.3.2.6 | Neoplasms |
15134534 |
Leukotriene A4 hydrolase as a target for cancer prevention and therapy. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 4 |
3.3.2.6 | Neoplasms |
19531649 |
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. |
causal interaction therapeutic application unassigned |
1 4 0 |
3.3.2.6 | Neoplasms |
20952510 |
Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A4 hydrolase. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 1 4 2 |
3.3.2.6 | Neoplasms |
24366255 |
Expression Analysis of Leukotriene-Inflammatory Gene Interaction Network in Patients with Coronary Artery Disease. |
causal interaction diagnostic usage unassigned |
4 2 0 |
3.3.2.6 | Neoplasms |
24385243 |
Positioning of aminopeptidase inhibitors in next generation cancer therapy. |
causal interaction therapeutic application unassigned |
4 4 0 |
3.3.2.6 | Neoplasms |
30058075 |
Leukotriene A4 hydrolase: an emerging target of natural products for cancer chemoprevention and chemotherapy. |
causal interaction therapeutic application unassigned |
4 4 0 |